P. Mitchell Et Al. , "Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study," PLOS ONE , vol.15, no.6, 2020
Mitchell, P. Et Al. 2020. Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study. PLOS ONE , vol.15, no.6 .
Mitchell, P., Sheidow, T. G., Farah, M. E., Mahmood, S., Minnella, A. M., Eter, N., ... Eldem, B.(2020). Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study. PLOS ONE , vol.15, no.6.
Mitchell, Paul Et Al. "Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study," PLOS ONE , vol.15, no.6, 2020
Mitchell, Paul Et Al. "Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study." PLOS ONE , vol.15, no.6, 2020
Mitchell, P. Et Al. (2020) . "Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study." PLOS ONE , vol.15, no.6.
@article{article, author={Paul Mitchell Et Al. }, title={Effectiveness and safety of ranibizumab 0.5 mg in treatment-naive patients with diabetic macular edema: Results from the real-world global LUMINOUS study}, journal={PLOS ONE}, year=2020}